pharma-话题@MedSci

#pharma#

608篇内容 | 2491人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1908352, encodeId=3dfa19083528d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur J Clin Pharmacol：益生菌联合三联疗法治疗儿童幽门螺杆菌感染, objectType=article, longId=119555, objectId=c10f11955573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c10f11955573, replyNumber=0, likeNumber=162, createdTime=2017-12-18, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c10f11955573, moduleTitle=Eur J Clin Pharmacol：益生菌联合三联疗法治疗儿童幽门螺杆菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c10f11955573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908344, encodeId=2e1519083441b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacoepidemiol Drug Saf：预防乳腺癌的潜力股——双膦酸盐, objectType=article, longId=118572, objectId=d83d1185e23a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d83d1185e23a, replyNumber=0, likeNumber=79, createdTime=2018-05-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d83d1185e23a, moduleTitle=Pharmacoepidemiol Drug Saf：预防乳腺癌的潜力股——双膦酸盐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d83d1185e23a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908285, encodeId=3f241908285a3, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：广藿香挥发油提取物对抗LPS诱导的急性肺损伤——抑制NF-κB和激活Nrf2通路, objectType=article, longId=105928, objectId=ad3c105928a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad3c105928a6, replyNumber=0, likeNumber=73, createdTime=2018-05-12, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad3c105928a6, moduleTitle=Int Immunopharmacol：广藿香挥发油提取物对抗LPS诱导的急性肺损伤——抑制NF-κB和激活Nrf2通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad3c105928a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908350, encodeId=d913190835094, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur J Clin Pharmacol：牙医处方抗菌药不合理, objectType=article, longId=119553, objectId=a08111955315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a08111955315, replyNumber=0, likeNumber=89, createdTime=2018-05-11, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a08111955315, moduleTitle=Eur J Clin Pharmacol：牙医处方抗菌药不合理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a08111955315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908428, encodeId=169519084287b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：过敏性鼻炎患者中，IL-1R8的表达增加且其配体IL-37具有免疫调节作用, objectType=article, longId=139180, objectId=8aed13918051, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8aed13918051, replyNumber=0, likeNumber=79, createdTime=2018-06-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8aed13918051, moduleTitle=Int Immunopharmacol：过敏性鼻炎患者中，IL-1R8的表达增加且其配体IL-37具有免疫调节作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8aed13918051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908415, encodeId=8b5d1908415ed, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=《药学学报》Acta Pharmaceutica Sinica B的IF或近6分, objectType=article, longId=135854, objectId=a18513585448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18513585448, replyNumber=0, likeNumber=67, createdTime=2018-09-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18513585448, moduleTitle=《药学学报》Acta Pharmaceutica Sinica B的IF或近6分, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18513585448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908307, encodeId=ec22190830e61, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：商陆皂苷甲或能治疗神经炎性疾病, objectType=article, longId=111209, objectId=cd751112098f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd751112098f, replyNumber=0, likeNumber=157, createdTime=2018-05-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd751112098f, moduleTitle=Int Immunopharmacol：商陆皂苷甲或能治疗神经炎性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd751112098f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908390, encodeId=cb6d1908390ed, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmaceut Res：乳腺癌耐药蛋白（BCRP / ABCG2）在人源性远端肺上皮细胞中的表达及活性, objectType=article, longId=125690, objectId=6ae512569073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ae512569073, replyNumber=0, likeNumber=53, createdTime=2018-06-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ae512569073, moduleTitle=Pharmaceut Res：乳腺癌耐药蛋白（BCRP / ABCG2）在人源性远端肺上皮细胞中的表达及活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ae512569073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908317, encodeId=c2fd190831e42, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：利用DNA芯片检测遗传性听力损失基因, objectType=article, longId=114377, objectId=1e571143e72a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e571143e72a, replyNumber=0, likeNumber=67, createdTime=2018-03-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e571143e72a, moduleTitle=Eur Rev Med Pharmacol Sci：利用DNA芯片检测遗传性听力损失基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e571143e72a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908295, encodeId=77a4190829542, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：研究发现可有效治疗湿疹的一种安全蛋白质！, objectType=article, longId=108105, objectId=a96710810547, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a96710810547, replyNumber=0, likeNumber=80, createdTime=2017-08-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a96710810547, moduleTitle=Int Immunopharmacol：研究发现可有效治疗湿疹的一种安全蛋白质！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a96710810547)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908283, encodeId=0a8f1908283dc, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Ann Pharmacother：基于指南证据评估ICU超说明书用药特征, objectType=article, longId=104444, objectId=d6e8104444e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6e8104444e6, replyNumber=0, likeNumber=63, createdTime=2017-12-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6e8104444e6, moduleTitle=Ann Pharmacother：基于指南证据评估ICU超说明书用药特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6e8104444e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908338, encodeId=789019083389d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacoepidemiol Drug Saf：黑框警告前后儿童和青少年抗抑郁药处方趋势如何？, objectType=article, longId=117741, objectId=e0bf11e74102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0bf11e74102, replyNumber=0, likeNumber=65, createdTime=2018-08-12, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0bf11e74102, moduleTitle=Pharmacoepidemiol Drug Saf：黑框警告前后儿童和青少年抗抑郁药处方趋势如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0bf11e74102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908397, encodeId=8b06190839e60, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Pharmacy Pra Res：低剂量阿司匹林怎么吃才能达到更佳效果，近期研究给出解释, objectType=article, longId=128749, objectId=0ed2128e4975, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ed2128e4975, replyNumber=0, likeNumber=70, createdTime=2018-12-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ed2128e4975, moduleTitle=J Pharmacy Pra Res：低剂量阿司匹林怎么吃才能达到更佳效果，近期研究给出解释, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ed2128e4975)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908406, encodeId=68db190840635, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Aliment Pharmacol Ther：停药or继续治疗？HBeAg阳性患者NA治疗获得HBeAg血清学转换后……, objectType=article, longId=132313, objectId=bb6013231302, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb6013231302, replyNumber=0, likeNumber=91, createdTime=2019-01-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb6013231302, moduleTitle=Aliment Pharmacol Ther：停药or继续治疗？HBeAg阳性患者NA治疗获得HBeAg血清学转换后……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb6013231302)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908385, encodeId=7b7f190838542, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=EUR J PHARMACOL：二甲双胍阻断由刺激α1-和α2-肾上腺素能受体介导的血管加压素反应的药理学证据, objectType=article, longId=124941, objectId=5a5b12494193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a5b12494193, replyNumber=0, likeNumber=59, createdTime=2018-10-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a5b12494193, moduleTitle=EUR J PHARMACOL：二甲双胍阻断由刺激α1-和α2-肾上腺素能受体介导的血管加压素反应的药理学证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a5b12494193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908323, encodeId=4a9519083234f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacotherapy：ACS：三种口服抗血小板药物治疗的临床结局, objectType=article, longId=115969, objectId=c83c1159696b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c83c1159696b, replyNumber=0, likeNumber=56, createdTime=2017-11-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c83c1159696b, moduleTitle=Pharmacotherapy：ACS：三种口服抗血小板药物治疗的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c83c1159696b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908376, encodeId=cba719083e6a9, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Aliment Pharmacol Ther：肥胖和二型糖尿病是先前未确诊的肝硬化患者的重要危险因素, objectType=article, longId=122823, objectId=f2d51228235e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2d51228235e, replyNumber=0, likeNumber=76, createdTime=2018-10-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2d51228235e, moduleTitle=Aliment Pharmacol Ther：肥胖和二型糖尿病是先前未确诊的肝硬化患者的重要危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2d51228235e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908300, encodeId=c767190830004, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Br J Clin Pharmacol：妊娠期使用哪些抗菌药物与重大先天畸形风险相关？, objectType=article, longId=108264, objectId=4c21108264a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c21108264a7, replyNumber=0, likeNumber=67, createdTime=2018-05-18, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c21108264a7, moduleTitle=Br J Clin Pharmacol：妊娠期使用哪些抗菌药物与重大先天畸形风险相关？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c21108264a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908388, encodeId=3ef91908388f1, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Evalutate Pharma：全球Top20制药企业展望, objectType=article, longId=125398, objectId=f8ea125398e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ea125398e3, replyNumber=0, likeNumber=64, createdTime=2018-01-08, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ea125398e3, moduleTitle=Evalutate Pharma：全球Top20制药企业展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8ea125398e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908365, encodeId=7f311908365c4, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacoepidem Dr S:罗格列酮的临床证据和药品监管变化对降糖治疗处方模式的影响, objectType=article, longId=121659, objectId=20bd121659dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20bd121659dc, replyNumber=0, likeNumber=71, createdTime=2018-07-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20bd121659dc, moduleTitle=Pharmacoepidem Dr S:罗格列酮的临床证据和药品监管变化对降糖治疗处方模式的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20bd121659dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

pharma

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur J Clin Pharmacol：益生菌联合三联疗法治疗儿童幽门螺杆菌感染

2017-12-18

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacoepidemiol Drug Saf：预防乳腺癌的潜力股——双膦酸盐

2018-05-22

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：广藿香挥发油提取物对抗LPS诱导的急性肺损伤——抑制NF-κB和激活Nrf2通路

2018-05-12

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur J Clin Pharmacol：牙医处方抗菌药不合理

2018-05-11

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：过敏性鼻炎患者中，IL-1R8的表达增加且其配体IL-37具有免疫调节作用

2018-06-05

chentianping (审核中...)

前往app查看评论内容

#pharma#

《药学学报》Acta Pharmaceutica Sinica B的IF或近6分

2018-09-13

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：商陆皂苷甲或能治疗神经炎性疾病

2018-05-27

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmaceut Res：乳腺癌耐药蛋白（BCRP / ABCG2）在人源性远端肺上皮细胞中的表达及活性

2018-06-23

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：利用DNA芯片检测遗传性听力损失基因

2018-03-04

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：研究发现可有效治疗湿疹的一种安全蛋白质！

2017-08-20

chentianping (审核中...)

前往app查看评论内容

#pharma#

Ann Pharmacother：基于指南证据评估ICU超说明书用药特征

2017-12-20

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacoepidemiol Drug Saf：黑框警告前后儿童和青少年抗抑郁药处方趋势如何？

2018-08-12

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Pharmacy Pra Res：低剂量阿司匹林怎么吃才能达到更佳效果，近期研究给出解释

2018-12-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

Aliment Pharmacol Ther：停药or继续治疗？HBeAg阳性患者NA治疗获得HBeAg血清学转换后……

2019-01-04

chentianping (审核中...)

前往app查看评论内容

#pharma#

EUR J PHARMACOL：二甲双胍阻断由刺激α1-和α2-肾上腺素能受体介导的血管加压素反应的药理学证据

2018-10-20

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacotherapy：ACS：三种口服抗血小板药物治疗的临床结局

2017-11-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

Aliment Pharmacol Ther：肥胖和二型糖尿病是先前未确诊的肝硬化患者的重要危险因素

2018-10-31

chentianping (审核中...)

前往app查看评论内容

#pharma#

Br J Clin Pharmacol：妊娠期使用哪些抗菌药物与重大先天畸形风险相关？

2018-05-18

chentianping (审核中...)

前往app查看评论内容

#pharma#

Evalutate Pharma：全球Top20制药企业展望

2018-01-08

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacoepidem Dr S:罗格列酮的临床证据和药品监管变化对降糖治疗处方模式的影响

2018-07-19

科室
- - 订阅+
  - 更多科室
工具
服务